Immunogenicity of BNT162b2 in children 6 months to under 5 years of age with previous SARS-CoV-2 infection, in the era of Omicron predominance

Background: Children 6 months to < 5 years old are recommended to receive 3-dose regimen of BNT162b2. Children previously infected with Omicron variant of SARS-CoV-2 develop immunity from natural infection, therefore may require fewer doses of vaccine. Objective: To compare immunogenicity of 1- or 2...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rapisa Nantanee, Peera Jaru-Ampornpan, Napaporn Chantasrisawad, Orawan Himananto, Supawan Papakhee, Jiratchaya Sophonphan, Monta Tawan, Thidarat Jupimai, Suvaporn Anugulruengkitt, Thanyawee Puthanakit
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-12-01
coleção:	Vaccine: X
Assuntos:	SARS-CoV-2 vaccine Child Infant Neutralizing antibody titer Anti-SARS-CoV-2 IgG BNT162b2 vaccine
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2590136223001080
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!